Pharmafile Logo
Pharmafocus logo
Advanced Search

Celebrex approved for new arthritis indication

August 8, 2005
Sales and Marketing

Celebrex has received US approval for a new indication as Pfizer looks to revive tumbling sales of its flagship COX- …

News

Home tests to be offered to beat bowel cancer

August 5, 2005

News

DTC advertising to be tightened up

August 4, 2005
Medical Communications

New US guidelines for pharmaceutical DTC advertising will come into effect next year as the industry seeks to address public …

News

Teva’s modest sales growth driven by MS treatment

August 4, 2005
Sales and Marketing

Teva Pharmaceuticals, the world's number one generics manufacturer, has posted modest second quarter results driven by its patent-protected multiple sclerosis …

News

Animal rights attacks curbed by new legislation

August 4, 2005

Animal rights activists have dramatically scaled back illegal attacks on medical researchers in the wake of new laws to counteract …

News

AstraZeneca name McKillop’s successor as sales rise

August 3, 2005
Sales and Marketing

Sir Tom McKillop is to step down in January as chief executive of AstraZeneca laying to rest speculation about the …

News

Survival of the fittest

August 1, 2005
Sales and Marketing

The title for this piece was inspired by a sort of scientific hobby I have, which revolves around critical thinking …

Feature

Personalising medicine

August 1, 2005
Research and Development

Hard times have hit the drug development industry. Faced with declining returns and the apparent waning of blockbusters, coupled with …

Feature

Devolution and the new customers

August 1, 2005

Feature

Seretide helps GSK overcome production problems

August 1, 2005
Manufacturing and Production

News

Pfizer demands action after counterfeit Lipitor recovered in UK

July 29, 2005
Manufacturing and Production

Pfizer has demanded strict new anti-counterfeiting measures in the UK and across Europe following the discovery of fake versions of …

News

PCT mergers and commissioning changes to be decided in 2006

July 29, 2005

News

Schering-Plough’s new anti-fungal gains EMEA approval

July 29, 2005
Sales and Marketing

A new treatment for fungal infections has been given a positive opinion by the EMEA.Schering-Plough's Noxafil (posaconazole) is a novel …

News

New drug-resistant HIV treatment recommended

July 28, 2005
Sales and Marketing

Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been recommended for approval by the European regulator.The prevalence of …

News

Financial failings undermine improvements in NHS

July 28, 2005

News

Red Door bought by marketing services group

July 26, 2005
Medical Communications

News

NICE calls for more Alzheimer’s evidence to head off row

July 20, 2005

Manufacturers of three Alzheimer's treatments have been asked to supply more information to NICE to help decide whether or not …

News

PR group launched to counter pharma’s poor public image

July 20, 2005
Medical Communications

A new forum has been launched to promote dialogue between healthcare stakeholders and improve public perception of the pharma industry.The …

News

New 28-day pack for Cozaar launched

July 20, 2005
Sales and Marketing

A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK.The 50mg …

News

Arixtra approved for new blood clot indication

July 20, 2005
Sales and Marketing Arixtra, GlaxoSmithKline

GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026